Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: Implications for neuroprotection

Molecular Neurobiology

Volumn 49, Issue 1, 2014, Pages 222-233

  Da Silva, Vanessa Kappel ^a,b   De Freitas, Betânia Souza ^a   Da Silva Dornelles, Arethuza ^a   Nery, Laura Roesler ^a   Falavigna, Lucio ^a   Ferreira, Rafael Dal Ponte ^a   Bogo, Maurício Reis ^a,b   Hallak, Jaime Eduardo Cecílio ^b,c   Zuardi, Antônio Waldo ^b,c   Crippa, José Alexandre S ^b,c   Schröder, Nadja ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b National Institute for Translational Medicine INCT TM   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Cannabidiol; Iron; Mitochondria; Neurodegenerative disorders

Indexed keywords

BRAIN PROTEIN; CANNABIDIOL; CASPASE 3; IRON; MITOCHONDRIAL PROTEIN; PROTEIN DNM1L; PROTEIN OPA1; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; CELL DEATH; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; FRONTAL CORTEX; HIPPOCAMPUS; IRON OVERLOAD; MALE; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; NEUROPROTECTION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REVIEW; SYNAPSE VESICLE; WISTAR RAT;

ANIMALS; BRAIN; CANNABIDIOL; CASPASE 3; DYNAMINS; FEMALE; GENE EXPRESSION REGULATION; IRON OVERLOAD; MALE; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; NEUROPROTECTIVE AGENTS; PREGNANCY; RANDOM ALLOCATION; RATS; RATS, WISTAR; SYNAPTOPHYSIN;

EID: 84894372100     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8514-7     Document Type: Review

References (61)

1. Stankiewicz JM, Brass SD (2009) Role of iron in neurotoxicity: a cause for concern in the elderly? Curr Opin Clin Nutr Metab Care 12(1):22-29
2. Mills E, Dong XP, Wang F, Xu H (2010) Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med Chem 2(1):51-64
3. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953-1975
4. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56(2):446-451
5. Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 31(3):286-292
6. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5(11):863-873
7. Schenck JF, Zimmerman EA, Li Z, Adak S, Saha A, Tandon R et al (2006) High-field magnetic resonance imaging of brain iron in Alzheimer disease. Top Magn Reson Imaging 17(1):41-50
8. Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA et al (2007) Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68(21):1820-1825
9. Zhu WZ, Zhong WD, Wang W, Zhan CJ, Wang CY, Qi JP et al (2009) Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 253(2):497-504
10. Pujol J, Junqué C, Vendrell P, Grau JM, Martí-Vilalta JL, Olivé C et al (1992) Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch Neurol 49(7):711-717
11. Sullivan EV, Adalsteinsson E, Rohlfing T, Pfefferbaum A (2009) Relevance of iron deposition in deep gray matter brain structures to cognitive and motor performance in healthy elderly men and women: exploratory findings. Brain Imaging Behav 3(2):167-175
12. Bartzokis G, Lu PH, Tingus K, Peters DG, Amar CP, Tishler TA et al (2011) Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology 36(7):1375-1384
13. Penke L, Valdés Hernandéz MC, Maniega SM, Gow AJ, Murray C, Starr JM et al (2012) Brain iron deposits are associated with general cognitive ability and cognitive aging. Neurobiol Aging 33(3):510-517
14. Rodrigue KM, Daugherty AM, Haacke EM, Raz N (2012) The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory. Cereb Cortex, DOI: 10.1093/cercor/bhs139
15. Brass SD, Benedict RH, Weinstock-Guttman B, Munschauer F, Bakshi R (2006) Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 12(4):437-444
16. House MJ, St Pierre TG, Foster JK, Martins RN, Clarnette R (2006) Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. AJNR Am J Neuroradiol 27(2):430-439
17. Ding B, Chen KM, Ling HW, Sun F, Li X, Wan T et al (2009) Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease. J Magn Reson Imaging 29(4):793-798
18. Fredriksson A, Schröder N, Eriksson P, Izquierdo I, Archer T (1999) Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol 159(1):25-30
19. Schröder N, Fredriksson A, Vianna MR, Roesler R, Izquierdo I, Archer T (2001) Memory deficits in adult rats following postnatal iron administration. Behav Brain Res 124(1):77-85
20. de Lima MN, Polydoro M, Laranja DC, Bonatto F, Bromberg E, Moreira JC et al (2005) Recognition memory impairment and brain oxidative stress induced by postnatal iron administration. Eur J Neurosci 21(9):2521-2528
21. Schröder N, Figueiredo LS, de Lima MNM (2013) Role of brain iron accumulation in cognitive dysfunction: evidence from animal models and human studies. J Alzheimers Dis 34(4):797-812
22. Liu W, Tian F, Kurata T, Morimoto N, Abe K (2012) Dynamic changes of mitochondrial fusion and fission proteins after transient cerebral ischemia in mice. J Neurosci Res 90(6):1183-1189
23. Wang X, Su B, Zheng L, Perry G, Smith MA, Zhu X (2009) The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Neurochem 109(1):153-159
24. Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwarzenbacher R, Lipton SA (2003) Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol 15(6):706-716
25. Harris JJ, Jolivet R, Attwell D (2012) Synaptic energy use and supply. Neuron 75(5):762-777
26. Shimada A, Keino H, Satoh M, Kishikawa M, Hosokawa M (2003) Age-related loss of synapses in the frontal cortex of SAMP10 mouse: a model of cerebral degeneration. Synapse 48(4):198-204
27. Kajta M (2004) Apoptosis in the central nervous system: Mechanisms and protective strategies. Pol J Pharmacol 56(6):689-700
28. Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (-) Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A 95(14):8268-8273
29. García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J (2007) Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res 1134(1):162-170
30. Castillo A, Tolón MR, Fernández-Ruiz J, Romero J, Martinez-Orgado J (2010) The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiol Dis 37(2):434-440
31. Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo AA (2004) Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem 89(1):134-141
32. Pazos MR, Cinquina V, Gómez A, Layunta R, Santos M, Fernández-Ruiz J et al (2012) Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology 63(5):776-783
33. Sagredo O, Ramos JA, Decio A, Mechoulam R, Fernández-Ruiz J (2007) Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. Eur J Neurosci 26(4):843-851
34. Fagherazzi EV, Garcia VA, Maurmann N, Bervanger T, Halmenschlager LH, Busato SB et al (2012) Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology (Berlin) 219(4):1133-1140
35. Karl T, Cheng D, Garner B, Arnold JC (2012) The therapeutic potential of the endocannabinoid system for Alzheimer's disease. Expert Opin Ther Targets 16(4):407-420
36. Silva PF, Garcia VA, da Dornelles AS, Silva VK, Maurmann N, Portal BC et al (2012) Memory impairment induced by brain iron overload is accompanied by reduced H3K9 acetylation and ameliorated by sodium butyrate. Neuroscience 200:42-49
37. Arciello M, Capo CR, Cozzolino M, Ferri A, Nencini M, Carrì MT et al (2010) Inactivation of cytochrome c oxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide. J Neurochem 112(1):183-192
38. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
39. Amaral AU, Seminotti B, Cecatto C, Fernandes CG, Busanello EN, Zanatta A et al (2012) Reduction of Na(+), K(+)-ATPase activity and expression in cerebral cortex of glutaryl-CoA dehydrogenase deficient mice: A possible mechanism for brain injury in glutaric aciduria type I. Mol Genet Metab 107(3):375-382
40. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
41. Bonefeld BE, Elfving B, Wegener G (2008) Reference genes for normalization: a study of rat brain tissue. Synapse 62:302-309
42. Kar R, Mishra N, Singha PK, Venkatachalam MA, Saikumar P (2010) Mitochondrial remodeling following fission inhibition by 15d-PGJ2 involves molecular changes in mitochondrial fusion protein OPA1. Biochem Biophys Res Commun 399(4):548-554
43. Loucks FA, Schroeder EK, Zommer AE, Hilger S, Kelsey NA, Bouchard RJ et al (2009) Caspases indirectly regulate cleavage of the mitochondrial fusion GTPase OPA1 in neurons undergoing apoptosis. Brain Res 1250:63-74
44. Evans LC, Liu H, Thompson LP (2012) Differential effect of intrauterine hypoxia on caspase 3 and DNA fragmentation in fetal guinea pig hearts and brains. Reprod Sci 19(3):298-305
45. Manczak M, Reddy PH (2012) Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21(11):2538-2547
46. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y et al (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105(49):19318-19323
47. Horowitz MP, Greenamyre JT (2010) Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis 20(Suppl 2):S551-S568
48. Dal-Pizzol F, Klamt F, Frota ML, Andrades ME, Caregnato FF, Vianna M et al (2001) Neonatal iron exposure induces oxidative stress in adult Wistar rat. Brain Res Dev Brain Res 130:109-114
49. Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ (1997) Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 56(8):933-944
50. Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W Jr et al (2005) Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J Alzheimers Dis 7(2):103-117
51. Youle RJ, Karbowski M (2005) Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 6(8):657-663
52. Chan DC (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125(7):1241-1252
53. Miwa CP, de Lima MN, Scalco F, Vedana G, Mattos R, Fernandez LL et al (2011) Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats. Neurotox Res 19(4):527-535
54. Salvador GA, Oteiza PI (2011) Iron overload triggers redox-sensitive signals in human IMR-32 neuroblastoma cells. Neurotoxicology 32(1):75-82
55. Avramovich-Tirosh Y, Reznichenko L, Mit T, Zheng H, Fridkin M, Weinreb O et al (2007) Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron-chelating-antioxidants, M-30 and green tea polyphenol, EGCG. Curr Alzheimer Res 4(4):403-411
56. Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G et al (2011) Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend 114(2-3):242-245
57. Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S et al (2013) Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol 27(1):19-27
58. 2+ levels. J Neurosci 29(7):2053-2063
59. LeVine SM, Bilgen M, Lynch SG (2013) Iron accumulation in multiple sclerosis: an early pathogenic event. Expert Rev Neurother 13(3):247-250
60. de Lima MN, Presti-Torres J, Garcia VA, Guimarães MR, Scalco FS, Roesler R et al (2008) Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats. Neuropharmacology 55(5):788-792
61. Perez VP, de Lima MN, da Silva RS, Dornelles AS, Vedana G, Bogo MR et al (2010) Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways. Curr Neurovasc Res 7(1):15-22